- Instruments
- Reagents
- Kits
- Software
- Services
Neurological Disorder Diagnostics Market size was valued at USD x million in 2022 and is poised to grow at a CAGR of X% from 2023-2029
Global Neurological Disorder Diagnostics Market Summary
Study Period
2023-2029
Base Year
2023
CAGR
x%
Largest Market
N/A
Fastest Growing Market
N/A
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Neurological Disorder Diagnostics Market Segmentation
By Component
By Technology
- Immunoassay
- PCR Techniques
By Disease Type
- Alzheimer's Sisease
- Dementia
- Parkinson's Disease
- Epilepsy
- Traumatic Brain Injury
- Others
By End User
- Hospitals
- Clinics, Diagnostic Centers
- Academic
- Research Institutes
Frequently Asked Questions
The neurological disorder diagnostics market key players are: Hoffmann La Roche Ltd., Creative Biolabs, Diadem Srl, Fujirebio Diagnostics, Quest Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary | ||
| 2. Global Neurological Disorder Diagnostics Market Introduction | ||
| 2.1. Global Neurological Disorder Diagnostics Market Taxonomy | ||
| 2.2. Global Neurological Disorder Diagnostics Market Definitions | ||
| 2.2.1. By Component | ||
| 2.2.2. By Technology | ||
| 2.2.3. By Disease Type | ||
| 2.2.4. By End User | ||
| 2.2.5. By Region | ||
| 3. Global Neurological Disorder Diagnostics Market Dynamics | ||
| 3.1. Drivers | ||
| 3.2. Restraints | ||
| 3.3. Opportunities/Unmet Needs of the Market | ||
| 3.4. Trends | ||
| 3.5. Global Neurological Disorder Diagnostics Market Dynamic Factors - Impact Analysis | ||
| 3.6. Global Neurological Disorder Diagnostics Market Competition Landscape | ||
| 3.7. Epidemiology | ||
| 4. Global Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 | ||
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) | ||
| 4.3. Market Opportunity Analysis | ||
| 5. Global Neurological Disorder Diagnostics Market, By Component, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 5.1. Instruments | ||
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 5.1.3. Market Opportunity Analysis | ||
| 5.2. Reagents and Kits | ||
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 5.2.3. Market Opportunity Analysis | ||
| 5.3. Software and Services | ||
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 5.3.3. Market Opportunity Analysis | ||
| 6. Global Neurological Disorder Diagnostics Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 6.1. Immunoassay | ||
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 6.1.3. Market Opportunity Analysis | ||
| 6.2. PCR Techniques | ||
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 6.2.3. Market Opportunity Analysis | ||
| 7. Global Neurological Disorder Diagnostics Market, By Disease Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.1. Alzheimers Disease | ||
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.1.3. Market Opportunity Analysis | ||
| 7.2. Dementia | ||
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.2.3. Market Opportunity Analysis | ||
| 7.3. Parkinson's Disease | ||
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.3.3. Market Opportunity Analysis | ||
| 7.4. Epilepsy | ||
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.4.3. Market Opportunity Analysis | ||
| 7.5. Traumatic Brain Injury | ||
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.5.3. Market Opportunity Analysis | ||
| 7.6. Others | ||
| 7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 7.6.3. Market Opportunity Analysis | ||
| 8. Global Neurological Disorder Diagnostics Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 8.1. Hospitals and Clinics | ||
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 8.1.3. Market Opportunity Analysis | ||
| 8.2. Diagnostic Centers | ||
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 8.2.3. Market Opportunity Analysis | ||
| 8.3. Academic and Research Institutes | ||
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 8.3.3. Market Opportunity Analysis | ||
| 9. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.1. North America | ||
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 9.1.3. Market Opportunity Analysis | ||
| 9.2. Europe | ||
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 9.2.3. Market Opportunity Analysis | ||
| 9.3. Asia-Pacific | ||
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 9.3.3. Market Opportunity Analysis | ||
| 9.4. Latin America | ||
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 9.4.3. Market Opportunity Analysis | ||
| 9.5. Middle East and Africa | ||
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) | ||
| 9.5.3. Market Opportunity Analysis | ||
| 9.6. Global Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Technology, By Disease Type, By End User, and Region, 2023 - 2029 | ||
| 10. North America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 10.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 10.1.1. Instruments | ||
| 10.1.2. Reagents and Kits | ||
| 10.1.3. Software and Services | ||
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 10.2.1. Immunoassay | ||
| 10.2.2. PCR Techniques | ||
| 10.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 10.3.1. Alzheimers Disease | ||
| 10.3.2. Dementia | ||
| 10.3.3. Parkinson's Disease | ||
| 10.3.4. Epilepsy | ||
| 10.3.5. Traumatic Brain Injury | ||
| 10.3.6. Others | ||
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 10.4.1. Hospitals and Clinics | ||
| 10.4.2. Diagnostic Centers | ||
| 10.4.3. Academic and Research Institutes | ||
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) | ||
| 10.5.1. USA | ||
| 10.5.2. Canada | ||
| 10.6. North America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029 | ||
| 10.7. North America Neurological Disorder Diagnostics Market Dynamics Trends | ||
| 11. Europe Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 11.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 11.1.1. Instruments | ||
| 11.1.2. Reagents and Kits | ||
| 11.1.3. Software and Services | ||
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 11.2.1. Immunoassay | ||
| 11.2.2. PCR Techniques | ||
| 11.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 11.3.1. Alzheimers Disease | ||
| 11.3.2. Dementia | ||
| 11.3.3. Parkinson's Disease | ||
| 11.3.4. Epilepsy | ||
| 11.3.5. Traumatic Brain Injury | ||
| 11.3.6. Others | ||
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 11.4.1. Hospitals and Clinics | ||
| 11.4.2. Diagnostic Centers | ||
| 11.4.3. Academic and Research Institutes | ||
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) | ||
| 11.5.1. Germany | ||
| 11.5.2. UK | ||
| 11.5.3. France | ||
| 11.5.4. Spain | ||
| 11.5.5. Italy | ||
| 11.5.6. Russia | ||
| 11.5.7. Rest of Europe | ||
| 11.6. Europe Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029 | ||
| 11.7. Europe Neurological Disorder Diagnostics Market Dynamics Trends | ||
| 12. Asia-Pacific Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 12.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 12.1.1. Instruments | ||
| 12.1.2. Reagents and Kits | ||
| 12.1.3. Software and Services | ||
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 12.2.1. Immunoassay | ||
| 12.2.2. PCR Techniques | ||
| 12.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 12.3.1. Alzheimers Disease | ||
| 12.3.2. Dementia | ||
| 12.3.3. Parkinson's Disease | ||
| 12.3.4. Epilepsy | ||
| 12.3.5. Traumatic Brain Injury | ||
| 12.3.6. Others | ||
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 12.4.1. Hospitals and Clinics | ||
| 12.4.2. Diagnostic Centers | ||
| 12.4.3. Academic and Research Institutes | ||
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) | ||
| 12.5.1. China | ||
| 12.5.2. India | ||
| 12.5.3. Japan | ||
| 12.5.4. ASEAN | ||
| 12.5.5. Australia & New Zealand | ||
| 12.5.6. Rest of Asia-Pacific | ||
| 12.6. Asia-Pacific Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, by Disease Type, By End User, and Country, 2023 - 2029 | ||
| 12.7. Asia-Pacific Neurological Disorder Diagnostics Market Dynamics Trends | ||
| 13. Latin America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 13.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 13.1.1. Instruments | ||
| 13.1.2. Reagents and Kits | ||
| 13.1.3. Software and Services | ||
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 13.2.1. Immunoassay | ||
| 13.2.2. PCR Techniques | ||
| 13.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 13.3.1. Alzheimers Disease | ||
| 13.3.2. Dementia | ||
| 13.3.3. Parkinson's Disease | ||
| 13.3.4. Epilepsy | ||
| 13.3.5. Traumatic Brain Injury | ||
| 13.3.6. Others | ||
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 13.4.1. Hospitals and Clinics | ||
| 13.4.2. Diagnostic Centers | ||
| 13.4.3. Academic and Research Institutes | ||
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) | ||
| 13.5.1. Brazil | ||
| 13.5.2. Mexico | ||
| 13.5.3. Rest of Latin America | ||
| 13.6. Latin America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029 | ||
| 13.7. Latin America Neurological Disorder Diagnostics Market Dynamics Trends | ||
| 14. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) | ||
| 14.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 14.1.1. Instruments | ||
| 14.1.2. Reagents and Kits | ||
| 14.1.3. Software and Services | ||
| 14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) | ||
| 14.2.1. Immunoassay | ||
| 14.2.2. PCR Techniques | ||
| 14.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 14.3.1. Alzheimers Disease | ||
| 14.3.2. Dementia | ||
| 14.3.3. Parkinson's Disease | ||
| 14.3.4. Epilepsy | ||
| 14.3.5. Traumatic Brain Injury | ||
| 14.3.6. Others | ||
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) | ||
| 14.4.1. Hospitals and Clinics | ||
| 14.4.2. Diagnostic Centers | ||
| 14.4.3. Academic and Research Institutes | ||
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) | ||
| 14.5.1. Gulf CoEnd User Council (GCC) Countries | ||
| 14.5.2. South Africa | ||
| 14.5.3. Rest of MEA | ||
| 14.6. MEA Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029 | ||
| 14.7. MEA Neurological Disorder Diagnostics Market Dynamics Trends | ||
| 15. Competition Landscape | ||
| 15.1. Strategic Dashboard of Top Market Players | ||
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) | ||
| 15.2.1. F. Hoffmann La Roche Ltd. | ||
| 15.2.2. Creative Biolabs | ||
| 15.2.3. Diadem Srl | ||
| 15.2.4. Fujirebio Diagnostics | ||
| 15.2.5. Quest Diagnostics | ||
| 15.2.6. Thermo Fisher Scientific, Inc. | ||
| 15.2.7. Bio-Rad Laboratories, Inc. | ||
| 15.2.8. Siemens Healthineers | ||
| 16. Research Methodology | ||
| 17. Appendix and Abbreviations | ||
- Hoffmann La Roche Ltd.
- Creative Biolabs
- Diadem Srl
- Fujirebio Diagnostics
- Quest Diagnostics
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers